AMYLIN PHARMACEUTICALS INC: capex

Value{"amount": 27532000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2010-01-01 – 2010-03-31
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-11-127421 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/capex/2010-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/af60fb8d-e83b-4c58-9a40-1e73b2feee9a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies